The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 229, 421-428
Abstract
No abstract availableKeywords
Funding Information
- H. Lundbeck A/S
This publication has 58 references indexed in Scilit:
- COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONSDepression and Anxiety, 2013
- The economic cost of brain disorders in EuropeEuropean Journal of Neurology, 2011
- Do Productivity Costs Matter?PharmacoEconomics, 2011
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive DisorderJournal of Medicinal Chemistry, 2011
- Subjective perception of cognition is related to mood and not performanceEpilepsy & Behavior, 2009
- Mediators of the association between depression and role functioningActa Psychiatrica Scandinavica, 2008
- Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I studyContemporary Clinical Trials, 2007
- Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorderClinical Practice & Epidemiology in Mental Health, 2007
- Development of a Brief Scale of Everyday Functioning in Persons with Serious Mental IllnessSchizophrenia Bulletin, 2006
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979